ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NewAmsterdam Pharma raises $196m through Series A funding round pharmaceutical-technology
January 18, 2021Clinical stage company NewAmsterdam Pharma (NAP) has raised $196m (€160m) through Series A funding round to support the full Phase III development of its ApoB and LDL-c lowering small molecule drug, obicetrapib.
Pharma Sources Insight January 2025
